| Systematic (IUPAC) name | |
|---|---|
| [(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3,5-dichlorobenzoate | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 40796-97-2 |
| ATC code | None |
| PubChem | CID 671690 |
| ChemSpider | 10498629 |
| UNII | O98T3677PA |
| ChEMBL | CHEMBL376379 |
| Chemical data | |
| Formula | C15H17Cl2NO2 |
| Mol. mass | 314.207 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Bemesetron (MDL-72,222) is a drug which acts as an antagonist at the 5HT3 receptor.[1] It has antiemetic effects comparable to metoclopramide,[2] however it is not used clinically, instead its main application is in scientific research studying the involvement of the 5HT3 receptor in the actions of drugs of abuse.[3][4][5][6]
|
||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
| This drug article relating to the gastrointestinal system is a stub. You can help Wikipedia by expanding it. |
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)